Скачать или смотреть Novo Nordisk 2025Q3 : Novo Nordisk Q3 2025 Earnings: Sales Up, Guidance Narrowed!

Dive into the Novo Nordisk Q3 2025 earnings call summary! We break down their strong first 9 months of 2025, with 15% sales growth and 10% operating profit increase (at constant exchange rates). Discover why they've narrowed their full-year guidance to 8-11% sales growth and 4-7% operating profit growth, focusing on GLP-1 treatment performance. Hear CEO Mike Doustdar's strategic vision for diabetes, obesity, and related comorbidities. Don't miss this essential update for investors!

🔔 Subscribe for more stock analysis and financial news: [Your YouTube Channel Link]
👍 Like this video if you found it helpful!

#NovoNordisk #EarningsCall #StockMarket #Investing #Pharma #Diabetes #Obesity #GLP1 #FinancialNews #NVO

Earn up to 17% with P2P Ventus: https://ventus.energy/join/U5MBHNau

Earn up to 16% with P2P Lendermarket: https://app2.lendermarket.com/de/empf...

The information presented here is for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell financial products. Any decisions you make based on this information are your own responsibility.